About MRA » Letter from the President
Today marks the start of Melanoma Awareness Month, and it comes at a time of remarkable progress and excitement in the field of melanoma research. Eight new drugs have been approved for melanoma in five years, strengthening our ability to help those suffering with this disease.
Even with these exciting developments, the death rate for patients with advanced melanoma is still far too high. And rates of melanoma are continuing to rise, at a time when cancer rates overall have declined. Prevention and early detection remain the best strategy for improving outcomes for patients with melanoma.
MRA remains passionate about funding cutting-edge research around the world, improving understanding of the therapies that work best, and continuing to accelerate the development of treatment options for patients. Here are four ways you can help during Melanoma Awareness Month:
If you need more information or would like to talk about additional opportunities, please contact Logan Kastner, Director of Marketing and Development.
Thanks for your continued support in our fight against melanoma.
Wendy K.D. Selig
President and CEO
MELANOMA RESEARCH ALLIANCE FOUNDATION (Melanoma Research Alliance; MRA) is a GuideStar Exchange Gold Participant Want to learn more about the GuideStar Exchange?
Click here »